UroGen Pharma (URGN) Financials

$44.09

$-0.79 (-1.76%)

As on 04-Sep-2026 16:00EDT

Market cap

$2,155 Mln

Revenue (TTM)

$189 Mln

P/E Ratio

--

P/B Ratio

16.2

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-162.44	-96.77	-76.38	-87.56	-84.89
Cash Flow from Investing Activities	--	61.56	-20.61	-0.95	1.06	4.07
Cash from Financing Activities	--	39.92	194.62	116.93	97.13	72.32
Net Cash Inflow / Outflow	--	--	--	--	10.64	-8.50

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.98	-3.12	-2.70	-2.83	-4.75	-4.94
Cash EPS ($)	-1.97	-3.07	-2.67	-2.78	-4.68	-4.86
Adjusted Book Value ($)	-2.71	--	--	--	--	0.38
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.30	-2.06	-2.11	-3.79	-3.78
Free Cash Flow per Share ($)	--	-3.31	-2.06	-2.12	-3.80	-3.82

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-223.36	-170.57	-465.33	-1,182.18	-207.79
ROE (%)	--	268.63	342.83	132.29	271.24	-211.55
ROA (%)	-34.21	-63.14	-54.68	-65.14	-85.98	-91.68
EBIT Margin (%)	-38.55	-125.76	-105.85	-75.03	-121.25	-227.66
Net Margin (%)	-51.73	-139.81	-140.35	-123.61	-167.95	-229.66
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	100.27	0.21	0.09	0.29	0.34	3.07
EBIT Growth (%)	44.16	-44.30	-54.18	20.47	28.65	13.70
Net Profit Growth (%)	37.00	-20.98	-24.09	6.87	0.94	13.75
EPS Growth (%)	40.19	-0.16	0.05	0.41	0.04	0.15
Book Value Growth (%)	-34.36	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-7.51	-3.95	-5.30	-1.87	-1.93
Price / Book Value	16.23	-10.93	-56.90	-8.32	-2.29	25.36
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.63	-8.56	-4.06	-8.36	-2.68	-1.15
Close Price ($)	36.80	23.42	10.65	15.00	8.87	9.51
High Price ($)	37.88	30.00	20.70	24.13	12.63	28.20
Low Price ($)	12.73	3.42	10.26	7.60	4.85	8.68
Market Cap ($ Cr)	2,155.14	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	-1.43	-1.22	-14.02	-1.52	-1.11	0.05
Short term debt to equity ratio	-0.02	--	-0.17	-0.01	-0.01	0.40
Current Ratio	3.80	4.01	6.01	5.42	5.39	5.11
Quick Ratio	3.41	3.65	5.81	5.24	5.21	4.90
Interest Coverage	-1.84	-4.08	-7.64	-4.22	-9.25	-6.27

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	47.03	30.13	22.46	18.67	19.74	24.39
Asset Turnover	0.66	0.45	0.39	0.53	0.50	0.40
Receivable days	--	88.80	72.21	62.15	69.30	71.33
Inventory Days	--	376.94	306.40	195.05	218.49	240.67
Payable days	--	338.46	358.73	234.91	269.93	320.74
Cash Conversion Cycle	--	127.29	19.88	22.29	17.86	-8.74

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.